Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development of cancer. Celecoxib may be effective in preventing lung cancer in tobacco
smokers.
PURPOSE: Phase II trial to study the effectiveness of celecoxib in preventing non-small cell
lung cancer in tobacco smokers.